| scholarly article | Q13442814 |
| P356 | DOI | 10.1159/000350142 |
| P8608 | Fatcat ID | release_6tapop4nrrcxdm2sayw2gcfjly |
| P698 | PubMed publication ID | 23689440 |
| P5875 | ResearchGate publication ID | 236923706 |
| P50 | author | Afschin Gandjour | Q40277267 |
| Charles Christian Adarkwah | Q40277835 | ||
| Silvia M Evers | Q55437100 | ||
| P2093 | author name string | Maren Akkerman | |
| P2860 | cites work | Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial | Q44280775 |
| P433 | issue | 2-3 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 168-180 | |
| P577 | publication date | 2013-05-06 | |
| P1433 | published in | Kidney and Blood Pressure Research | Q15765784 |
| P1476 | title | To treat or not to treat? Cost-effectiveness of ace inhibitors in non-diabetic advanced renal disease - a Dutch perspective | |
| P478 | volume | 37 |
| Q55476982 | Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD). |
| Q90392805 | Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design |
| Q53662831 | End-stage renal disease and adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among patients with diabetes. |
| Q88920000 | Hyperfiltration-mediated Injury in the Remaining Kidney of a Transplant Donor |
| Q64096237 | Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model |
| Q30234324 | Reducing the costs of chronic kidney disease while delivering quality health care: a call to action |
Search more.